Literature DB >> 4800569

Cisternal myelography using Conray.

E Hitchcock, I Dinakar.   

Abstract

Conray-280 (meglumine iothalamate) can be injected safely into the cisterna magna in the human. In this series of 46 patients no complications were encountered attributable to the irritant effects of Conray. Satisfactory radiographic visualization was obtained in 87% of cases using 5 ml. 50% solution of Conray-280 enabling clear delineation of the anterior and posterior borders of the spinal cord to be made.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4800569      PMCID: PMC494484          DOI: 10.1136/jnnp.36.5.877

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  9 in total

1.  VENTRICULOGRAPHY AND MYELOGRAPHY AND ABSORBABLE RADIOPAQUE MEDIUM.

Authors:  R L CAMPBELL; J A CAMPBELL; R F HEIMBURGER; J E KALSBECK; J MEALEY
Journal:  Radiology       Date:  1964-02       Impact factor: 11.105

2.  [Cerebral ventriculography with water soluble positive contrast medium (methylglucamine iothalamate)].

Authors:  F Isamat; A M Miranda; F Bartumeus
Journal:  Neurochirurgie       Date:  1970-12       Impact factor: 1.553

3.  Stereotactic cervical myelotomy.

Authors:  E Hitchcock
Journal:  J Neurol Neurosurg Psychiatry       Date:  1970-04       Impact factor: 10.154

4.  Comparative study of the effects of Conray 280 and Dimer X in lumbar radiculography.

Authors:  J V Occleshaw; J N Holyland
Journal:  Br J Radiol       Date:  1971-12       Impact factor: 3.039

5.  Conray ventriculography.

Authors:  I Dinakar; S B Rao
Journal:  Neurol India       Date:  1971-03       Impact factor: 2.117

6.  Methylglucamine iothalamate 60 per cent for cerebral ventriculography.

Authors:  J Handa; H Handa
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1969-11

7.  Positive contrast cerebral ventriculography using water-soluble media. Clinical evaluation of 102 procedures using methyglucamine iothalamate 60 per cent.

Authors:  R F Heimburger; J E Kalsbeck; R L Campbell; J Mealey
Journal:  J Neurol Neurosurg Psychiatry       Date:  1966-08       Impact factor: 10.154

8.  Water-soluble contrast lumbar myelography with meglumine iothalamate (Conray).

Authors:  J Praestholm; J Lester
Journal:  Br J Radiol       Date:  1970-05       Impact factor: 3.039

9.  Water-soluble contrast myelography using meglumine iothalamate (Conray) with methylprednisolone acetate (Depo-Medrol).

Authors:  F M Davis; R C Llewellyn; H D Kirgis
Journal:  Radiology       Date:  1968-04       Impact factor: 11.105

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.